(Boursier.com) — Intrasense , a specialist in medical imaging software solutions and designer of Myrian, announces its participation in the Journées Francophones de Radiologie (JFR). The show will be held at the Palais des Congrès in Paris. The 2022 edition is dedicated to the continuity of care pathways and “digital health”. This international congress of medical imaging will bring together more than 10,000 visitors between October 7 and 10.
Intrasense will showcase its latest AI innovations
The new version of the Myrian platform will be presented by the Intrasense team. Myrian 2.10 is made up of new clinical applications that perfectly integrate new artificial intelligence algorithms at the service of the radiologist. Ergonomics have also been optimized to provide a more intuitive user experience.
The new versions of applications dedicated to vascular analysis, pulmonary monitoring and bone fracture detection examinations, natively integrating AI, will be particularly honored by the Intrasense teams during this show. A new application dedicated to dental scanner imaging will also enrich the Group’s clinical catalog, which offers its partners ever more complete and effective solutions.
Intrasense, partner of breast cancer screening training workshops
On the occasion of the JFR, the reference organizations for medical training Forcomed and the CERF join forces with Intrasense, with the aim of training radiology interns in the organization of breast cancer screening and quality control in digital mammography.
This collaboration is a new opportunity to strengthen Intrasense’s commitment to the user experience, and demonstrates the clinical value of its applications dedicated to women’s imaging. This alliance is part of the 5-year partnership concluded between Intrasense Forcomed in February 2022.
Intrasense will publish its 2022 half-year results on October 12. The company invites its shareholders to participate in the webinar organized on October 18 at 6 p.m. during which Nicolas Reymond, Chief Executive Officer, will detail and analyze the financial results and then answer questions.
©2022 Boursier.com